APO AB 300 (Abacavir Sulfate 300 mg (base))
Pill with imprint APO AB 300 is Yellow, Capsule-shape and has been identified as Abacavir Sulfate 300 mg (base). It is supplied by Apotex Corp.
Abacavir is used in the treatment of hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Abacavir 300 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).
Images for APO AB 300
Abacavir Sulfate
- Imprint:
- APO AB 300
- Strength:
- 300 mg (base)
- Color:
- Yellow
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Apotex Corp
- Inactive Ingredients:
- silicon dioxide colloidal
magnesium stearate
microcrystalline cellulose
hypromelloses
polyethylene glycol 8000
ferric oxide yellow
croscarmellose sodium
titanium dioxide
Note: Inactive ingredients may vary.
Other Labelers / Repackagers:
| NDC Code | Labeler / Repackager |
|---|---|
| 00904-6523 | Major Pharmaceuticals |
More about abacavir
- Abacavir Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
Consumer resources
Other brands: Ziagen
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
